Vortuxi 500 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Vortuxi 500 mg Injection

Vortuxi 500 mg Injection

Vortuxi 500 mg Injection contains rituximab, a monoclonal antibody used mainly to treat certain blood cancers and autoimmune conditions. It is administered by intravenous infusion under the supervision of a qualified healthcare professional. Rituximab targets CD20-positive B cells, helping the immune system destroy abnormal cells.

BUY NOW

Category

Vortuxi 500 mg Injection is used for conditions including non-Hodgkin lymphoma and chronic lymphocytic leukaemia, as well as selected autoimmune disorders such as rheumatoid arthritis. Rituximab binds to the CD20 protein on B cells and promotes their elimination through immune-mediated mechanisms. The medicine is given as a controlled intravenous infusion according to the prescribed treatment protocol. Patients should be monitored for infusion reactions, infections, and other treatment-related effects during therapy.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Manufacturer Zydus Lifesciences Limited

Product Also Known As

Vortuxi 500 mg Injection, Vortuxi 500 Injection, Vortuxi Rituximab Injection, Rituximab 500 mg Injection, Rituximab Cancer Injection, Rituximab Monoclonal Antibody Injection